Skip to content
Agency·Rule·4 months ago

CMS Proposes 2026 Medicare Physician Pay Updates, Tightening Rules on Part B Drug Price Penalties

Impact Analysis

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Key Points

  • Starting Jan. 1, 2026, Medicare updates how it pays doctors and other clinicians for visits, tests, and procedures.
  • Doctor pay rates rise a bit overall, but not equally: one pay rate for clinicians in certain value-based programs, another for everyone else.
  • Medicare tightens and updates rules for Part B drugs, including how it calculates penalties when drug prices rise faster than inflation.
  • Accountable Care Organizations in the Medicare Shared Savings Program face updated rules on quality and how patients are counted.
  • The rule also updates policies for telehealth, diabetes prevention services, rural clinics, health centers, ambulances, and quality reporting.
Medicare MedicaidHealthcareEconomy Finance

What Happens Next

Projected impacts based on AI analysis

2027-2028

CMS may propose using updated practice expense survey data

CMS is still evaluating the AMA's 2024 practice expense survey data and may propose incorporating it into future payment calculations. If adopted, this could significantly redistribute payments across medical specialties based on updated cost information.

Related News

2 articles
Fierce Healthcare·4 months ago

CMS finalizes increased pay rates for physicians in 2026, but hospital docs could lose out

CMS finalized a 2026 pay rule increasing physician reimbursement by 3.77% for value-based providers and 3.26% for others. While top-line rates rise due to the 'One Big Beautiful Bill Act,' new efficiency adjustments and site-of-service payment changes may result in net cuts for hospital-based docs.

C~
Holland & Knight·4 months ago

CMS Releases CY 2026 Medicare Physician Fee Schedule Final Rule

The final rule confirms that beginning in 2026, Medicare will use separate conversion factors for clinicians in Advanced APMs ($33.57) versus others ($33.40). It also clarifies ASP reporting for drugs sold at a Maximum Fair Price and updates the Medicare Prescription Drug Inflation Rebate Program.

C=

Source Information

Document Type

Federal Rule

Official Title

Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.